Risk factors and prevention of dabigatran‐related gastrointestinal bleeding in patients with atrial...
Risk factors and prevention of dabigatran‐related gastrointestinal bleeding in patients with atrial fibrillation
About this item
Full title
Author / Creator
Publisher
Japan: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Japan: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Introduction
Dabigatran, as compared with warfarin, was associated with lower rates of stroke and systemic embolism with similar rates of major hemorrhage. But it has a significantly higher risk of gastrointestinal bleeding (GIB). There are limited data on how to prevent GIB from dabigatran and what are the risk factors.
Methods
We perform...
Alternative Titles
Full title
Risk factors and prevention of dabigatran‐related gastrointestinal bleeding in patients with atrial fibrillation
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5828263
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5828263
Other Identifiers
ISSN
1880-4276
E-ISSN
1883-2148
DOI
10.1002/joa3.12015
